Free from artificial colours, artificial flavours, aromas, preservatives and stabilisers.
Combination therapy options: Vitamin C therapy becomes even more powerful when combined with other IV nutrients
BPC-157s safety profile appears favorable based on animal trials
References Abdalrahman SS, Smail HO, Shallal AF
In findings from a phase 2a trial that were presented at the American Diabetes Association Scientific Sessions and simultaneously published in The Lancet , 71% of adults receiving coadministered cagrilintide and semaglutide 2.4 mg, dubbed CagriSema (Novo Nordisk), lost at least 10% of their body weight, and 89% of adults achieved an HbA1c of less than 7% with the combination therapy
Tendon and Muscle Repair: This peptide has shown promising results in promoting the repair and regeneration of tendons and muscles, potentially reducing the recovery time from injuries [6]